Bloks Group Limited — Earnings Release 2002

Jul 24, 2002

Listed Company Information

HK PHARMA<00182> - Results Announcement (Summary) Hong Kong Pharmaceutical Holdings Limited announced on 24/7/2002: (stock code: 182) Year end date: 31/3/2002 Currency: HKD Auditors' Report: Unqualified Review of Interim Report by: N/A (Audited) (Audited) Last Current Corresponding Period Period from 1/4/2001 from 1/4/2000 to 31/3/2002 to 31/3/2001 ('000) ('000) Turnover : 71,063 39,006 Profit/(Loss) from Operations : (17,224) (11,067) Finance cost : (6,385) (5,869) Share of Profit/(Loss) of Associates : - - Share of Profit/(Loss) of Jointly Controlled Entities : - - Profit/(Loss) after Tax & MI : (19,559) (15,296) % Change over Last Period : N/A EPS/(LPS)-Basic : (1.42 cents) (1.37 cents) -Diluted : N/A N/A Extraordinary (ETD) Gain/(Loss) : - - Profit/(Loss) after ETD Items : (19,559) (15,296) Final Dividend per Share : NIL NIL (Specify if with other options) : - - B/C Dates for Final Dividend : - Payable Date : - B/C Dates for (-) General Meeting : - Other Distribution for Current Period : - B/C Dates for Other Distribution : - Remarks: 1. Certain comparative figures have been reclassified to conform to the current year's presentation. 2. LOSS PER SHARE The calculation of basic loss per share is based on the net loss from ordinary activities attributable to shareholders for the year of approximately HK$19,559,000 (2001: approximately HK$15,296,000), and the weighted average number of 1,374,136,424 (2001: 1,119,928,205) ordinary shares in issue during the year. Diluted loss per share amounts for the years ended 31 March 2002 and 2001 have not been presented because the effects of the assumed conversion of the share options and convertible notes of the Company during these years were anti-dilutive.